Published in J Neurosci on February 03, 2016
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development (1993) 58.26
A Drosophila model of Parkinson's disease. Nature (2000) 7.82
New uses for old drugs. Nature (2007) 5.86
Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol (2009) 5.65
Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov (2007) 4.83
Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease. Nat Genet (2001) 4.63
Glutamate exocytosis from astrocytes controls synaptic strength. Nat Neurosci (2007) 4.43
Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science (2001) 4.25
A regenerative approach to the treatment of multiple sclerosis. Nature (2013) 3.42
Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in Drosophila. Dev Cell (2008) 2.66
Local caspase activity directs engulfment of dendrites during pruning. Nat Neurosci (2006) 2.65
Astrocytes mediate in vivo cholinergic-induced synaptic plasticity. PLoS Biol (2012) 2.49
Human wild-type tau interacts with wingless pathway components and produces neurofibrillary pathology in Drosophila. Neuron (2002) 2.28
Astrocyte calcium signaling transforms cholinergic modulation to cortical plasticity in vivo. J Neurosci (2011) 2.17
Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease. Ann Neurol (2005) 2.16
Identification of small molecules rescuing fragile X syndrome phenotypes in Drosophila. Nat Chem Biol (2008) 2.04
Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J (1995) 1.82
Astrocytic neurotransmitter receptors in situ and in vivo. Prog Neurobiol (1997) 1.76
Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice. Am J Pathol (1998) 1.65
Mice lacking glial fibrillary acidic protein display astrocytes devoid of intermediate filaments but develop and reproduce normally. EMBO J (1995) 1.62
Drosophila mutants with opposing effects on nerve excitability: genetic and spatial interactions in repetitive firing. J Neurophysiol (1982) 1.58
Mice devoid of the glial fibrillary acidic protein develop normally and are susceptible to scrapie prions. Neuron (1995) 1.57
Human neurodegenerative disease modeling using Drosophila. Annu Rev Neurosci (2003) 1.53
Astroglial excitability and gliotransmission: an appraisal of Ca2+ as a signalling route. ASN Neuro (2012) 1.40
Alexander disease-associated glial fibrillary acidic protein mutations in mice induce Rosenthal fiber formation and a white matter stress response. J Neurosci (2006) 1.37
Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission. J Neurosci (2010) 1.35
Alexander disease. J Neurosci (2012) 1.30
Nucleus basalis-enabled stimulus-specific plasticity in the visual cortex is mediated by astrocytes. Proc Natl Acad Sci U S A (2012) 1.30
Muscarinic acetylcholine receptors in the hippocampus, neocortex and amygdala: a review of immunocytochemical localization in relation to learning and memory. Prog Neurobiol (1999) 1.23
Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J Neurosci (2007) 1.19
Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction. Hum Mol Genet (2005) 1.18
Suppression of GFAP toxicity by alphaB-crystallin in mouse models of Alexander disease. Hum Mol Genet (2009) 1.14
Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells. Eur J Pharmacol (1996) 1.12
Calcium triggers exocytosis from two types of organelles in a single astrocyte. J Neurosci (2011) 1.08
Characterization and functional expression in mammalian cells of genomic and cDNA clones encoding a Drosophila muscarinic acetylcholine receptor. Proc Natl Acad Sci U S A (1989) 1.06
Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target. Sci Rep (2013) 1.03
A multiplicity of muscarinic mechanisms: enough signaling pathways to take your breath away. Proc Natl Acad Sci U S A (2000) 1.03
Functional expression of a cloned Drosophila muscarinic acetylcholine receptor in a stable Drosophila cell line. J Exp Biol (1995) 0.95
Cloning, sequence analysis and chromosome localization of a Drosophila muscarinic acetylcholine receptor. FEBS Lett (1989) 0.94
Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model. J Neurosci (2011) 0.92
Glial fibrillary tangles and JAK/STAT-mediated glial and neuronal cell death in a Drosophila model of glial tauopathy. J Neurosci (2010) 0.90
Systematic screen of chemotherapeutics in Drosophila stem cell tumors. Proc Natl Acad Sci U S A (2014) 0.90
A genetic RNAi screen for IP₃/Ca²⁺ coupled GPCRs in Drosophila identifies the PdfR as a regulator of insect flight. PLoS Genet (2013) 0.88
Abnormal intracellular calcium signaling and SNARE-dependent exocytosis contributes to SOD1G93A astrocyte-mediated toxicity in amyotrophic lateral sclerosis. J Neurosci (2014) 0.86
Nicotinic and muscarinic agonists and acetylcholinesterase inhibitors stimulate a common pathway to enhance GluN2B-NMDAR responses. Proc Natl Acad Sci U S A (2014) 0.82
Novel contribution of cell surface and intracellular M1-muscarinic acetylcholine receptors to synaptic plasticity in hippocampus. J Neurochem (2013) 0.79
Intracellular localization of the M1 muscarinic acetylcholine receptor through clathrin-dependent constitutive internalization is mediated by a C-terminal tryptophan-based motif. J Cell Sci (2014) 0.79
Treatment with LPS plus INF-γ induces the expression and function of muscarinic acetylcholine receptors, modulating NIH3T3 cell proliferation: participation of NOS and COX. Br J Pharmacol (2014) 0.76